These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39209505)

  • 41. Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma.
    Micheletti L; Preti M; Cintolesi V; Corvetto E; Privitera S; Palmese E; Benedetto C
    J Gynecol Oncol; 2018 Sep; 29(5):e61. PubMed ID: 30022627
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinicopathological risk factors in the light of the revised 2018 International Federation of Gynecology and Obstetrics staging system for early cervical cancer with staging IB: A single center retrospective study.
    Zeng J; Qu P; Hu Y; Sun P; Qi J; Zhao G; Gao Y
    Medicine (Baltimore); 2020 Apr; 99(16):e19714. PubMed ID: 32311956
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage III and IVA FIGO.
    Origoni M; Sideri M; Garsia S; Carinelli SG; Ferrari AG
    Gynecol Oncol; 1992 Jun; 45(3):313-6. PubMed ID: 1612509
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
    Sznurkowski JJ; Żawrocki A; Biernat W
    BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inguino-femoral radiotherapy in vulvar squamous cell carcinoma: clues to revised indications in patients with only one intracapsular lymph node metastasis.
    Serre E; Raimond E; Diguisto C; Bendifallah S; Body G; Touboul C; Graesslin O; Carcopino X; Daraï E; Ouldamer L;
    Acta Oncol; 2020 May; 59(5):518-524. PubMed ID: 31718368
    [No Abstract]   [Full Text] [Related]  

  • 46. Analysis of Lymph Node Metastasis and Risk Factors in 975 Patients with FIGO 2009 Stage IA-IIA Cervical Cancer.
    Cao L; Kong W; Li J; Song D; Jin B; Liu T; Han C
    Gynecol Obstet Invest; 2023; 88(1):30-36. PubMed ID: 36450266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unilateral versus bilateral lymph-nodal metastases and oncologic outcome in vulvar cancer patients.
    Papadia A; Ehm L; Gasparri ML; Wang J; Radan AP; Mueller MD
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1877-1881. PubMed ID: 32266536
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Melanoma of the Vulva and Vagina: Surgical Management and Outcomes Based on a Clinicopathologic Reviewof 68 Cases.
    Sinasac SE; Petrella TM; Rouzbahman M; Sade S; Ghazarian D; Vicus D
    J Obstet Gynaecol Can; 2019 Jun; 41(6):762-771. PubMed ID: 30391279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival.
    van der Velden J; van Lindert AC; Lammes FB; ten Kate FJ; Sie-Go DM; Oosting H; Heintz AP
    Cancer; 1995 Jun; 75(12):2885-90. PubMed ID: 7773938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival benefit of vaginectomy compared to local tumor excision in women with FIGO stage I and II primary vaginal carcinoma: a SEER study.
    Zhou W; Yue Y; Pei D
    Arch Gynecol Obstet; 2020 Dec; 302(6):1429-1439. PubMed ID: 32780160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis.
    van der Steen S; de Nieuwenhof HP; Massuger L; Bulten J; de Hullu JA
    Gynecol Oncol; 2010 Dec; 119(3):520-5. PubMed ID: 20875914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study.
    Woelber L; Eulenburg C; Kosse J; Neuser P; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Jückstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Ignatov A; Hillemanns P; Fürst S; Strauss HG; Mahner S; Prieske K;
    Gynecol Oncol; 2019 Sep; 154(3):571-576. PubMed ID: 31324454
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vulvar cancer recurrence - an analysis of prognostic factors in tumour-free pathological margins patients group.
    Minar L; Felsinger M; Cihalova M; Zlamal F; Bienertova-Vasku J
    Ginekol Pol; 2018; 89(8):424-31. PubMed ID: 30215461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Pelvic Lymph Node Resection in Vulvar Squamous Cell Cancer: A Subset Analysis of the AGO-CaRE-1 Study.
    Woelber L; Bommert M; Harter P; Prieske K; Zu Eulenburg C; Jueckstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Beckmann M; Mustea A; Meier W; Mahner S; Jaeger A
    Ann Surg Oncol; 2021 Oct; 28(11):6696-6704. PubMed ID: 33723714
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P; Tripcony L; Nicklin J
    Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The local treatment modalities in FIGO stage I-II small-cell carcinoma of the cervix are determined by disease stage and lymph node status.
    Zhou J; Yang HY; Wu SG; He ZY; Lin HX; Sun JY; Li Q; Guo ZW
    Cancer Med; 2016 Jun; 5(6):1108-15. PubMed ID: 26990881
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The prognostic value of the presence of pelvic and/or para-aortic lymph node metastases in cervical cancer patients; the influence of the new FIGO classification (stage IIIC).
    van Kol KGG; Ebisch RMF; van der Aa M; Wenzel HB; Piek JMJ; Bekkers RLM
    Gynecol Oncol; 2023 Apr; 171():9-14. PubMed ID: 36804623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors for recurrence and survival in primary vulvar squamous cell cancer.
    Ayhan A; Velipasaoglu M; Salman MC; Guven S; Gultekin M; Bayraktar O
    Acta Obstet Gynecol Scand; 2008; 87(11):1143-9. PubMed ID: 18949585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patterns of first recurrence and outcomes in surgically treated women with vulvar cancer: results from FRANCOGYN study group.
    Pirot F; Chaltiel D; Ouldamer L; Touboul C; Raimond E; Carcopino X; Daraï E; Bendifallah S
    J Gynecol Obstet Hum Reprod; 2020 Nov; 49(9):101775. PubMed ID: 32438137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.